Excel Venture Management is a Boston-based venture capital firm that builds companies applying transformative life science technologies to solve problems in healthcare and beyond. The portfolio is balanced across healthcare IT and services, diagnostics, medical devices, and life science platforms.
56% of their portfolio is in Healthcare. Their most common stage is series-b (44% of deals). Average disclosed round size is $16.4M (across 9 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Welldoc | Unknown | $29.5M | Mar 2016 |
| Welldoc | Series B | $22M | Dec 2015 |
 InfoBionic, Inc. | Series B | $8M | Jan 2014 |
| SShapeUp | Unknown | $7.5M | Nov 2013 |
 Aileron Therapeutics | Unknown | $12M | Jan 2013 |
 Saladax | Series C | $8.4M | Mar 2010 |
 InfoBionic | Series B | $17M | — |
| IIlluminOss Medical | Series C | $28M | — |
 Qstream | Series B | $15M | — |
Top Co-Investors
Launchpad Capital3 shared
Safeguard Scientifics, Inc.2 shared
Broadview Ventures2 shared
Alexandria Venture Investments2 shared
B372 shared
SR One2 shared
TCA Venture Group1 shared
Windham Capital Partners1 shared
Adage Capital Management1 shared
Roche Venture Fund1 shared
AJU IB Investment1 shared
Apple Tree Partners1 shared
Silicon Valley Bank1 shared
Cue Ball Capital1 shared
New Leaf Venture Partners1 shared
Tekla Capital Management1 shared
Pappas Capital1 shared
Frontline Ventures1 shared
Polaris Partners1 shared
Last updated: 8 September 2026